Studies in rat models of inflammatory bowel disease demonstrated that BPC-157 reduced mucosal inflammation markers and accelerated fistula closure [2]
Flynn McGuire at the University of Utah, for example, said: The amount of hype to evidence is so skewed, its crazy, and that BPC-157 Should not be used by humans. At the same time, other physicians and researchers see things differently, and are prescribing BPC-157 for a wide variety of illnesses and injuries: ulcerative colitis, orthopedic injuries, and even mental health
Some common signs and symptoms include: Decreased cognitive function, such as issues with memory or understanding Fatigue Lethargy Constipation Feeling faint Depression or irritability Headache Difficulty maintaining balance Sore, swollen tongue, which may be pale yellow or very red Heart palpitations Mouth ulcers Par anesthesia (pins and needles) Vision changes B-12 deficiency risk factors Both diabetes and some medications for type 2 diabetes can increase the risk of vitamin B-12 deficiency
It might also help athletes to recover faster from injuries
Key supporting research from 2024-2025 includes a July 2024 paper in Inflammopharmacology (PMID: 38980576) linking BPC-157 to stress response mechanisms, a January 2025 HSS Journal systematic review on neuromuscular applications (PMID: 40756949), and a 2025 Journal of Neuropsychiatry and Clinical Neurosciences perspectives paper positioning BPC-157 as an emerging therapeutic for CNS disorders
Instead of just describing how tired you feel, you can show them hard data, ensuring you get the right treatment plan